Related Articles
miR‑146b‑5p suppresses glioblastoma cell resistance to temozolomide through targeting TRAF6
Inhibition of STAT3 reverses drug resistance acquired in temozolomide-resistant human glioma cells
Estrogen receptor β agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathway
Momelotinib sensitizes glioblastoma cells to temozolomide by enhancement of autophagy via JAK2/STAT3 inhibition
PomGnT1 enhances temozolomide resistance by activating epithelial-mesenchymal transition signaling in glioblastoma